The Effect of Semi Fowler 30' Right Lateral on Cardiac Output in Acute Heart Failure

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06039397

Acronym

SETTLECO

Enrollment

Registered

2023-09-15

Start date

2023-09-01

Completion date

2023-12-30

Last updated

2024-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrythmia, Cardiac Output, High, Dyspnea; Cardiac, Heart Failure, Pulmonary Edema With Heart Failure

Keywords

Cardiac Output, Heart Failure, Body Positioning, Right Lateral Body Position, Semifowler

Brief summary

Heart failure is a special clinical syndrome such as difficulty breathing, fatigue, and swollen legs characterized by increased JVP, crackle lung sounds, and peripheral edema caused by heart disorders both structural and/or functional, resulting in decreased cardiac output and increased intracardiac pressure at rest and activity. Body positioning has been shown to affect stroke volume and parasympathetic modulating activity. The right lateral 30 semifowler position is a very safe position in heart failure patients admitted to the ICU. Although body positioning can affect stroke volume, and parasympathetic modulation, it is not yet clear what effect it has on cardiac output

Interventions

BEHAVIORALSemifowler 30' Right Lateral Body Position

Semifowler 30' Right Lateral Body Position Is a regulation of body position by placing the patient's body in a semi-fowler and lateral resting position of 30 degrees

Study design

Allocation

NON_RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* The patient was diagnosed with acute decompensated heart failure, * fully conscious, * not intubated, * \>18 years old, * had no mobility problems, * palpable radial artery pulsation, * was not under the influence of anti-hypotensive drugs, * willing to be a respondent, * LVEF \<50%.

Exclusion criteria

* Pulmonary edema, * severe valve disease comorbidities, * receiving high doses of anti-hypotensive treatment, * heart failure readmission in the last 3 months, * finger edema, * use of mechanical circulatory support, * irregular rhythms, * artificial pacemaker attached, * obesity * peripheral perfusion disorders * cardiogenic shock

Design outcomes

Primary

Measure	Time frame	Description
Cardiac Output	15 Minutes	The amount of blood volume pumped by the heart for 1 minute in liters

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026